Fintel reports that on July 14, 2025, Scotiabank initiated coverage of Gossamer Bio (NasdaqGS:GOSS) with a Sector Outperform recommendation. Analyst Price Forecast Suggests 470.53% Upside As of June ...

Gossamer Bio (NASDAQ:GOSS) has observed the following analyst ratings within the last quarter: These 4 analysts have an average price target of $18.5 versus the current price of Gossamer Bio at ...

So it might be obvious that you need to consider debt, when you think about how risky any given stock is, because too much debt can sink a company. We note that Gossamer Bio, Inc. (NASDAQ:GOSS) does h ...

Potential Gossamer Bio, Inc. (NASDAQ:GOSS) shareholders may wish to note that the COO & CFO, Bryan Giraudo, recently bought US$113k worth of stock, paying US$0.56 for each share.We reckon that's a ...

Over the past quarter, shares of Gossamer Bio have risen 24.23%, and are up 55.59% in the last year. On the other hand, the S&P 500 has only moved -12.41% and -10%, respectively.

Over the past 3 months, 5 analysts have published their opinion on Gossamer Bio (NASDAQ:GOSS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding ...